At the IGTP TODAY

News

- Research

A new cellular model reveals which mutations drive progression to myelodysplastic syndrome and leukemia in patients with GATA2 deficiency

A research team has created the first humanised cellular model to study GATA2 deficiency, a rare genetic disorder that predisposes individuals to severe blood conditions such as myelodysplastic syndrome and leukaemia. The study shows that, although the initial GATA2 mutation weakens haematopoietic stem cells, it is additional mutations -particularly in the SETBP1 gene- that drive disease progression. 

The Core Facilities of the Can Ruti Campus: cutting-edge technology driving excellence in research

At the Campus Can Ruti Core Facilities Infoday, the Josep Carreras Leukaemia Research Institute and the Germans Trias i Pujol Research Institute showcased their scientific services and the support they can offer to research conducted both on the campus and externally. The event also featured the presentation of the new IGTP-IJC Joint Flow Cytometry Unit, which has one of the most advanced infrastructures in the EU, as well as the new IJC's Translational-PATH2CURE hub, which aims to accelerate the translation of scientific discoveries into treatments for patients.

The Fundació Catalunya La Pedrera awards 33 Talents Grants to retain medical and research talent in Catalonia

The Talents Grants for the 2024 and 2025 editions have been granted by the Fundació Catalunya La Pedrera, supporting healthcare professionals in developing research projects that will lead to their doctoral theses. This initiative, originally created through a collaboration with the Research Institute and Hospital Germans Trias i Pujol, now also includes Hospital Clínic Barcelona, the Vall d'Hebron Institute of Oncology and Hospital de Bellvitge.

- Projects, Research

Micropores pave the way for infection research

A new study provides a powerful way to study infections in environments that closely mimic human organs. The strategy, tested in a bone-marrow-on-chip model, was developed by researchers from ISGlobal, IGTP, I3S at Porto University, and IN2UB, as part of the HIDDENVIVAX project, funded by "la Caixa" Foundation.

Awards for Research Career in Primary Care and for Best Article at the 16th Conference of Institut Català de la Salut, focused on cancer

The conference has been a meeting point and an opportunity to share strategies, knowledge and innovative projects that contribute to improving the health and quality of life of people affected by cancer. Pere Torán and Federico Fondelli, researchers affiliated with IGTP, have been recognised in the 2025 Research Awards.